WHO
REGULATORY UPDATE
1st Invitation to manufacturers of medicinal products for treatment of childhood cancer, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
Published: 10/2/2026Detected: 8/13/2026
Summary preview
Invites manufacturers to submit Expressions of Interest for WHO Prequalification evaluation of specific childhood cancer medicines, including six paediatric formulation priority products identified through a WHO PADO…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountoncology
pediatrics
manufacturing
quality
clinical
safety
labeling
#WHO prequalification
#Expression of Interest
#childhood cancer
#target product profile
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/2/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/2/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/2/2026
- New EUL listing10/2/2026
- Prequalification of In Vitro Diagnostics: Scope Expansion10/2/2026